Seed Cycling and Hormonal Balance: A Case Study of Successful Fertility Intervention in Polycystic Ovarian Syndrome
Abstract
This case study discusses the treatment of primary infertility in a 29-year-old female with a case of polycystic ovarian syndrome (PCOS) who presented to the Infertility Clinic at Wardha, Maharashtra, with a 2-year history of failed conception. The female patient complains about irregular menstrual cycles, mild acne, hair thinning weight gain, and hormonal imbalances characterized by high luteinizing hormone (LH), low levels of follicle-stimulating hormone (FSH), and a raised LH: FSH ratio. Following the initial evaluations, they were put on a comprehensive fertility treatment plan that incorporated Myo-inositol and folic acid supplementation, and seed cycling as a dietary intervention. The seed cycling protocol involved the consumption of ground flaxseeds and pumpkin seeds during the follicular phase and sunflower and sesame seeds during the luteal phase to balance estrogen and progesterone, respectively. After 6 months, the patient experienced notable improvements such as regular menstrual cycles, a reduction in body mass index ranges from 29 to 24 kg/m², normalized hormone levels, and the male partner's semen analysis representing results within normal limits. The couple moved forward with intracytoplasmic sperm injection, which led to the development of high-quality embryos and a confirmed clinical pregnancy outcome. This case highlights the effectiveness of integrating pharmacological treatment with seed cycling to improve fertility outcomes in patients with PCOS.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.